About
Craig Muir led the identification and integration of drug discovery and development technology platforms across Third Rock's portfolio, built platform systems for R&D and informatics, and contributed to scientific diligence. He helped expand the firm's San Francisco presence. He joined in 2007 and holds a B.S. in Physiology and Chemistry from UC Davis.
Invests in
BiotechDeep Tech
Deals · 1
Decibel Therapeutics, Inc.Board seat
via Third Rock Ventures · filed Jan 2017 · $57.8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Network5
Abbie Celniker
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Barbara Weber
Venture Partner at Third Rock Ventures
Investors connected to Craig in public investor directories — a warm-intro map.